MOTS-c: The Mitochondrial-Derived Peptide Redefining Metabolic and Longevity Research

Introduction

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) represents a paradigm shift in peptide biology. Unlike conventional peptides encoded by nuclear DNA, MOTS-c is a 16-amino acid peptide encoded directly within the mitochondrial genome — specifically within the 12S ribosomal RNA gene. First characterized by Lee et al. in 2015, MOTS-c has since emerged as one of the most compelling subjects in metabolic and longevity research, with studies demonstrating roles in glucose homeostasis, insulin sensitivity, exercise physiology, and aging biology [1].

The discovery of MOTS-c established that mitochondria are not merely passive energy-generating organelles but active endocrine signaling hubs capable of producing bioactive peptides that communicate with the nucleus, peripheral tissues, and systemic circulation.

Molecular Characteristics

MOTS-c consists of 16 amino acids with the sequence MRWQEMGYIFYPRKLR, encoded by a short open reading frame within the mitochondrial 12S rRNA gene. Its molecular weight is approximately 2,174 Daltons. The peptide is detected in human plasma, where circulating levels decline with age — a finding that has stimulated significant interest in its potential role as a biomarker of metabolic aging [2].

Unlike most mitochondrial gene products, MOTS-c can translocate from mitochondria to the cytoplasm and nucleus, where it directly influences gene expression and metabolic enzyme activity. This mitochondria-to-nucleus retrograde signaling capacity distinguishes MOTS-c from other mitochondrial-derived peptides (MDPs) such as Humanin.

Mechanism of Action

AMPK Activation and Glucose Metabolism

The primary metabolic mechanism of MOTS-c involves activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. In skeletal muscle cells, MOTS-c activates AMPK by inhibiting the folate cycle and de novo purine synthesis, leading to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) — a natural AMPK activator [1]. This cascade enhances glucose uptake via GLUT4 translocation and increases fatty acid oxidation in skeletal muscle.

Nuclear Translocation and Gene Regulation

Under metabolic stress conditions, MOTS-c translocates to the nucleus where it regulates gene expression through interaction with antioxidant response elements (ARE). This nuclear activity modulates expression of genes involved in oxidative stress response, mitochondrial biogenesis, and metabolic adaptation [3].

Insulin Sensitization

In rodent models of diet-induced obesity and type 2 diabetes, exogenous MOTS-c administration restored insulin sensitivity and reduced fasting glucose levels. The mechanism involves both peripheral AMPK activation in skeletal muscle and modulation of adipose tissue inflammation through reduction of pro-inflammatory cytokines including TNF-α and IL-6 [4].

Exercise Mimicry Research

One of the most striking findings in MOTS-c research is its role as an exercise-induced peptide. Reynolds et al. (2021) demonstrated that MOTS-c is released from skeletal muscle during physical activity and that circulating MOTS-c levels increase acutely following exercise in both humans and mice [5]. Exogenous MOTS-c administration in aged mice produced significant improvements in physical performance, including increased running capacity and endurance — effects that were observed even in sedentary animals.

This exercise mimicry property positions MOTS-c as a research tool for studying exercise-related metabolic adaptations in models where physical activity is not feasible, such as aged or metabolically impaired subjects.

Aging and Longevity Research

Circulating MOTS-c levels decline progressively with age in both humans and animal models. This age-associated decline correlates with deteriorating metabolic function, reduced insulin sensitivity, and increased visceral adiposity — suggesting MOTS-c may serve as both a biomarker of metabolic aging and a potential target for longevity interventions.

In aged mouse models, MOTS-c supplementation has been associated with improved glucose tolerance, reduced adipose tissue inflammation, enhanced mitochondrial function in skeletal muscle, improved physical performance and grip strength, and potential attenuation of age-related muscle loss (sarcopenia) [6].

Notably, MOTS-c has also been examined in the context of pancreatic islet preservation, with a 2025 Nature study demonstrating that MOTS-c prevents age-related islet dysfunction and reduces diabetes risk in aged mice [7].

Comparison with Related Mitochondrial Peptides

| Peptide | Size | Primary Research Focus | Key Pathway | |---|---|---|---| | MOTS-c | 16 aa | Metabolism, exercise, aging | AMPK, folate cycle | | Humanin | 21 aa | Neuroprotection, apoptosis | STAT3, IGF-1R | | SHLP2 | 12 aa | Mitochondrial function, apoptosis | Mitochondrial membrane | | SHLP6 | 8 aa | Apoptosis induction | Mitochondrial membrane |

For research use only. Not for human or animal consumption.

References

1. Lee, C., et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443–454.
2. Zempo, H., et al. (2021). Age-associated decline of MnSOD activity in mouse skeletal muscle: a possible role of MOTS-c. FASEB BioAdvances, 3(7), 479–489.
3. Kim, S.J., et al. (2018). Mitochondrially derived peptides as novel regulators of metabolism. Journal of Physiology, 596(24), 6423–6428.
4. Mohtashami, Z., et al. (2022). MOTS-c, the most recent mitochondrial derived peptide in human aging and its role in prevention of age-related diseases. International Journal of Molecular Sciences, 23(19), 11991.
5. Reynolds, J.C., et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12(1), 470.
6. Bhatt, M.P., et al. (2023). MOTS-c: A promising mitochondrial-derived peptide for therapeutic intervention in aging and metabolic disorders. Frontiers in Physiology, 14, 1602271.
7. Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet dysfunction. Nature, 2025.